[This review was originally posted at the Nieman Journalism Lab Glucophage Mg, on Oct. 15, 2010.]
Advances for paid content on the iPad: We start this week with a whole bunch of data points regarding journalism and mobile devices; I'll try to tie them together for you the best I can. Conde Nast, one of the world's largest magazine publishers, has done the most thorough iPad research we've seen so far, with more than 100 hours of in-person interviews and in-app surveys with more than 5, Glucophage used for, 000 respondents. Conde Nast released some of its findings this week, which included five pieces of advice for mobile advertisers that were heavy on interactivity and clear navigation. They also discovered some good news for mobile advertisers: The iPad's early users aren't simply the typical tech-geek early adopter set, and about four-fifths of them were happy with their experiences with Conde Nast's apps.
MocoNews had the most detailed look at Conde Nast's study, arguing that the fact that iPads are shared extensively means they're not being treated as a mobile device, buy generic Glucophage. Users also seemed to spend much more time with the mobile versions of the magazines than the print versions, though that data's a little cloudy, Glucophage Mg. NPR has also done some research on its users via Twitter and Facebook, and the Lab's Justin Ellis reported that they've found that those listeners are generally younger, hardcore listeners. Together, Facebook and Twitter account for 7 to 8 percent of NPR's web traffic, Online buying Glucophage, though Facebook generates six times as much as Twitter.
There were also a few items on newspapers and the iPad: Forbes' Jeff Bercovici reported that the New York Post will become the first newspaper without a paid website to start selling an iPad app subscription. The subscription is only sold inside the app, a strategy that The Next Web's Martin Bryant called a psychological trick that "makes users feel less like they’re paying for news and more like they’re 'Just buying another app.'" The British newspaper The Financial Times said its iPad app has made about £1 million in advertising revenue since it was launched in May, but as Poynter's Damon Kiesow noted, local papers have been slow to jump on the iPad train, with only a dozen of launching apps so far, Glucophage gel, ointment, cream, pill, spray, continuous-release, extended-release. Glucophage Mg, Meanwhile, GigaOM's Mathew Ingram ripped most magazine iPad apps for a lack of interactivity, openness or user control, saying,"the biggest flaw for me is the total lack of acknowledgment that the device this content appears on is part of the Internet, and therefore it is possible to connect the content to other places with more information about a topic."But some news organizations are already busy preparing for the next big thing: According to The Wall Street Journal, some national news orgs have begun developing content for Samsung's new tablet, the Galaxy, which is scheduled to be released later this year.
Too much of a good story?: Regardless of where you were this week, the huge story was the rescue of 33 Chilean miners who had been trapped underground for more than two months. The fact that it was such an all-encompassing story is, of course, a media story in itself: TV broadcasters planned wall-to-wall coverage beforehand, Herbal Glucophage, and that coverage garnered massive ratings in the U.S. and elsewhere. (We followed on the web, too.) With 2,000 journalists at the site, the event became a global media spectacle the likes of which we haven't seen in a while.
The coverage had plenty of critics, many of them upset about the excessive amount of resources devoted to a story with little long-term impact by news organizations that are making significant cuts to coverage elsewhere, Glucophage Mg. The point couldn't have been finer in the case of the BBC, comprar en línea Glucophage, comprar Glucophage baratos, which spent more than £100,000 on its rescue coverage, leading it to slash the budget for upcoming stories like the Cancun climate change meetings and Lisbon NATO summit.
The sharpest barbs belonged to NYU prof Jay Rosen and Lehigh prof Jeremy Littau. "The proportion of response to story impact is perhaps the best illustration of the insanity we seen in media business choices today," Littau wrote, Buy Glucophage without a prescription, adding,"I see an industry chasing hits and page views by wasting valuable economic and human capital." Lost Remote's Steve Safran pointed out that the degree of coverage had much more to do with the fact that coverage could be planned than with its newsworthiness.
Rupert keeps pushing into paywalls: After his Times and Sunday Times went behind a paywall this summer, Rupert Murdoch added another newspaper to his online paid-content empire this week: The British tabloid News of the World. Access to the paper's site will cost a pound a day or £1.99 for four weeks, and will include some web exclusives, including a new video section, no prescription Glucophage online. PaidContent gave the new site itself a good review Glucophage Mg, , saying it's an improvement over the old one.
The business plan behind the paywall didn't get such kind reviews. As with The Times' paywall, News of the World's content will be hidden from Google and other search engines, and while paidContent reported that its videos had been reposted on YouTube before the site even launched, the paper's digital editor told Journalism.co.uk that it's working aggressively to keep its content within the site, Glucophage wiki, including calling in the lawyers if need be. The Press Gazette's Dominic Ponsford argued that the new site formally marks Murdoch's retreat from the web: "Without any inbound or outbound links, and invisible to Google and other search engines, the NotW, Times and Sunday Times don’t really have internet sites – but digitally delivered editions."British journalist Kevin Anderson was a little more charitable, saying the strategy just might be an early step toward a frictionless all-app approach to digital news.
As for Murdoch's other paywall experiment at The Times, Glucophage class, two editors gave a recent talk (reported by Editors Weblog) that juxtaposed two interesting ideas: The editors claimed that a subscription-based website makes them more focused on the user, then touted this as an advantage of the iPad: "People consume how you want them to consume."
News orgs' kibosh on political participation: NPR created a bit of buzz this week when it sent a memo to employees explaining that they were not allowed to attend the upcoming rallies by comedians Jon Stewart and Stephen Colbert (unless they were covering the events), as they constitute unethical participation in a political rally. The rule forbidding journalists to participate in political rallies is an old one in newsrooms, and at least eight of the U.S.' largest news organizations told The Huffington Post their journalists also wouldn't be attending the rallies outside of work, Glucophage Mg.
NPR senior VP Dana Davis Rehm explained in a post on its site that NPR issued the memo to clear up any confusion about whether the rallies, which are at least partly satirical in nature, About Glucophage, were in fact political. NPR's fresh implementation prompted a new round of criticism of the longstanding rule, especially from those skeptical of efforts at "objective" journalism: The Wrap's Dylan Stableford called it "insane," Northeastern j-prof Dan Kennedy said the prohibition keeps journalists from observing and learning, and CUNY j-prof Jeff Jarvis made a similar point, arguing that "NPR is forbidding its employees to be curious."
A closer look at Denton and Huffington: In the past week, we've gotten long profiles of two new media magnates in a New Yorker piece on Gawker chief Nick Denton and a Forbes story on Arianna Huffington and her Huffington Post, Glucophage no rx. (Huffington also gave a good Q&A to Investor's Business Daily.) Reaction to the Denton articles was pretty subdued, but former Gawker editor Elizabeth Spiers (who wrote the Huffington piece) had some interesting thoughts about how Gawker has become part of the mainstream, though not everyone agrees whether its success is replicable.
Figures in the pieces prompted Reuters' Felix Salmon and Forbes' Jeff Bercovici to break down the sites' valuation. Glucophage Mg, (Salmon only looks at Gawker, though Bercovici compares the two in traffic value and in their owners' roles.) The two networks have long been rivals, and Denton noted that thanks to a couple of big sports-related scandals, Gawker's traffic beat the Post's for the first time ever this week. Also this week, Rx free Glucophage, Huffington announced she'd pay $250,000 to send buses to Jon Stewart's rally later this month, an idea the Wrap said some of her employees weren't crazy about.
Reading roundup: Busy, busy week this week. We'll see how much good stuff I can point you toward before your eyes start glazing over.
— A few follow-ups to last week's discussion of Howard Kurtz's move from The Washington Post to The Daily Beast: The New York Times' David Carr wrote a lyrical column comparing writing for print and for the web, Glucophage samples, PBS MediaShift's Mark Glaser interviewed Kurtzon Twitter, and former ESPN.com writer Dan Shanoff pointed out that the move from mainstream media to the web began in the sports world.
— An update on the debate over content farms: MediaWeek ran an article explaining why advertisers like them so much; one of those content farms, Demand Media said in an SEC filing that it plans to spend $50 million to $75 million on investments in content next year; and one hyperlocal operation accused of running on a content-farm model, AOL's Patch, responded to its critics' allegations, Glucophage Mg.
— Two interesting discussions between The Guardian and Jeff Jarvis: Guardian editor Alan Rusbridger posted some thoughts about his concept of the Fourth Estate — the traditional press, public media, and the web's public sphere — and Jarvis responded by calling the classification "correct but temporary." The Guardian's Roy Greenslade also wrote about his concern for the news/advertising divide as journalists become entrepreneurs, Glucophage dose, and Jarvis, an entrepreneurial journalism advocate, defended his cause.
— Three other good reads before we're done:
GigaOM's Mathew Ingram told newspapers it's better to join Groupon than to fight it.
Newspaper analyst Alan Mutter laid out French research that illuminates just how far digital natives' values are from those of the newspaper industry — and what a hurdle those newspapers have in reaching those consumers.
Scott Rosenberg looked at the closed systems encroaching on the web and asked a thought-provoking question: Is the openness that has defined the web destined to be just a parenthesis in a longer history of control. It's a big question and, as Rosenberg reminds us, a critical one for the future of news.
Similar posts: Purchase Flagyl. Buy Bactrim No Prescription. Zoloft No Rx. About Glucophage. Where can i order Glucophage without prescription. Cipro brand name.
Trackbacks from: Glucophage Mg. Glucophage Mg. Glucophage Mg. Glucophage dangers. Order Glucophage from United States pharmacy. Glucophage used for.
[This review was originally posted at the Nieman Journalism Lab Tramadol For Sale, on Sept. 10, 2010.]
An uneasy move into the world of web metrics: As CUNY j-prof C.W. Anderson declared on Twitter, this was "obviously the week of news metrics," so it's probably best to start there. Australia, uk, us, usa, The discussion was kicked off Monday by a New York Times feature on traditional news organizations beginning to pay more attention to their online traffic numbers — something most other websites have been doing religiously for years, but a relative novelty for traditionally one-way institutions such as the Times and The Washington Post. The Times' Jeremy Peters painted a picture of the Post's newsroom that didn't look all that different from Gawker Media in this respect: Traffic data gets displayed on a screen in the newsroom, emailed daily to staff members, and has played a role in staff-cutting decisions.
Still, editors at America's most prominent newspapers (the Times, the Post, The Wall Street Journal, and The Los Angeles Times were the four examined) were careful to note (somewhat dubiously) that they don't let that traffic dictate what they write about, Tramadol For Sale. The Post's media critic, Howard Kurtz, herbal Tramadol, weighed in on the phenomenon with some concern, pondering the balance between pushing for traffic and protecting a storied brand like the Post's or the Times'. "They can't simply abandon serious news in favor of the latest wardrobe malfunction without alienating some of their longtime readers," he said of the two papers. "What they gain in short-term hits would cost them in long-term reputation."
Naturally, Ordering Tramadol online, Gawker tweaked Kurtz for his paternal unease about the issue, mocking the idea that knowing and adjusting for what readers care about represents a threat to journalism. Econsultancy's Patricio Robles remarked that the Times didn't find any evidence of major news organizations being corrupted by the use of their traffic numbers and wondered why newspapers don't go further, like testing multiple versions of the same story. Tramadol For Sale, Meanwhile, Columbia researchers released a study that found that news organizations use metrics that vary widely in their measurements of online traffic, leading to confused editors and hesitant advertisers. The Columbia Journalism Review adapted the study into an article by Lucas Graves on the web's too-much-information problem and its effect on news organizations: "The Web has been hailed as the most measurable medium ever, and it lives up to the hype. The mistake was to assume that everyone measuring everything would produce clarity." On the other hand, online buy Tramadol without a prescription, Graves said, news decisions have been made easier in other media (like, say, TV) where metrics were not necessarily more accurate, but more unanimous. Tramadol description, —
Google Instant's impact on search: This week, Google unveiled another tool that might eventually have a significant effect on that web traffic: Google Instant, a change to its web search function (though it's coming to browsers soon) that allows users to see results for predicted searches as they type. Essentially, it takes Google's autocomplete feature and shows the results of those possible searches as well as the search terms themselves. Here, let Search Engine Land explain it to you — they're good at this, and they have pictures, Tramadol For Sale.
Google is selling this feature on the idea that it makes searching faster, though like Scott Rosenberg, Tramadol overnight, I'm not too interested in that aspect. (As TechCrunch's Erick Schonfeld pointed out, the bigger change is in the volume of search results you'll be processing, not the speed with which you'll get them.) The more significant issue is what this might do to industry of search-engine optimization. Google noted that websites and keyword ads will see some fluctuations in the number of impressions they get, Tramadol without prescription, and The Guardian has asuperb explanation of how SEO works and what Google Instant might do to it.
PR expert Steve Rubel was the first to speculate that Google Instant could kill SEO, arguing that it will serve as feedback that allows people to change their searches in real-time, rejecting inadequate search results and personalizing the web for themselves. "Google Instant means no one will see the same web anymore, making optimizing it virtually impossible," he said. (The Guardian Tramadol For Sale, also noted that if users are signed into their Google account, their results will also be personalized based on their web history.)
Quite a few people leaped to refute Rubel's point, with ReadWriteWeb quoting a marketer who speculated that top search results and "long-tail search" would gain even more value. Other arguments for the continued existence of SEO: as long as people are using search engines to find information, Tramadol used for, that information will need to be optimized (Search Engine Land); Google's search is still only as good as the content it finds (Econsultancy); SEO experts have already been planning around personalized search and Google Suggest (Vanessa Fox); and they'll continue to adapt to this increased personalization (Google's Matt Cutts).
A couple of people made the interesting case that Google Instant will actually reduce the individuality in web search: Searchers will stop once they see results for a popular search that's close enough to what they were looking for, the argument goes. Web entrepreneur Bob Warfield put the point well: "Instant Search will substitute popular searches for those individually created. More people will be driven off the back roads search trails and onto the superhighways that lead to whomever controls the first few search results connected to the Instant Searches Google is recommending at the time." It's a possibility that could have damaging implications for serendipity in finding alternative news voices online, too. Tramadol pics, —
NPR's targeted local push: We've been hearing for a while about NPR's new local-news web initiative, and this week NPR formally launched it as The Argo Network, a set of a dozen websites run by public-radio stations on specific local issues. PaidContent's Staci Kramer took a close look at what the network's sites look like and the thinking behind them, with NPR execs noting that the network's reporter-bloggers will take a web-first approach and that the underlying philosophy isn't much different from AOL's Patch hyperlocal-news project, Tramadol For Sale. The funding is, however; the project has $3 million to last it through next year, compared with Patch's gobs o' cash.
SF Weekly's Lois Beckett talked to NPR's Matt Thompson about the reporting ethos of the project: A focus on a passionate niche audience, Tramadol interactions, curation and community-building, and an emphasis on the news stream and news developments' context within larger stories. Here at the Lab, Ken Doctor was impressed by the indications that the project will be able to create and multiply audiences for itself and its member stations. "Like Silicon Valley startups, the effort is about building a product that seems to meet a clear audience need, About Tramadol, building that audience — and then finding a sustainable business model," he wrote. "That’s what has built companies for decades in the valley, and it’s in contrast to how much of the journalism business has long gotten funded."
Apple's app police and news: Apple issued revised guidelines for its App Store this week, summarized nicely at Daring Fireball and a little more comically at TechCrunch. You can find plenty of commentary Tramadol For Sale, on this from the developers' perspective, but there's a significant journalistic angle to this as well, as Apple's app store policies have generated a little bit of consternation in the past year.
Apple is using the "we'll know it when we see it" approach to determining what's inappropriate content, which Scott Rosenberg saw as pretty problematic for a platform that Apple's billing as the New Newsstand, Tramadol price, coupon. After running down excerpts from the guidelines in which Apple threatens imposing new rules on the spot and retaliating against developers who give them bad press, Rosenberg wrote, "Now read these questions from the perspective of a writer or journalist or publisher, not a software developer, and tell me they don’t give you the willies."
The Lab's Joshua Benton also examined Apple's rules from a news perspective, Tramadol reviews, expressing frustration at its limitation of its new political satire exception to professionals. "Defining who is a 'professional' when it comes to opinion-sharing is sketchy enough, but when it includes political speech and the defining is being done by overworked employees of a technology company, it’s odious," Benton said.
Reading roundup: Lots of interesting smaller discussions to poke around in this week. Here's a sampling:
— Two must-read pieces of advice for new journalists and journalism students: Jay Rosen's adaptation of his lecture last week (also linked to here last week) on the new users of journalism and how to serve them best, and Mark Briggs' case for studying journalism right now, Tramadol australia, uk, us, usa.
— We got the second quarter's ad numbers for newspapers, which were either a relief (according to the Newspaper Association of America) or another in a seemingly neverending series of low points (according to industry analyst Alan Mutter), Tramadol For Sale. In other depressing statistics, a report found that mainstream journalism jobs in the U.K. have decreased by nearly a third in the last decade.
— At TechCrunch, online video executive Ashkan Karbasfrooshan made his case against content farms from a marketing perspective ("should content producers really be conveying the fact that we’re cheap dates?"), Tramadol online cod, while web veteran John Battelle wrote a long, thoughtful post on whether one of those content farms, Demand Media, can adapt to an increasingly social web.
— New York Times Publisher Arthur Sulzberger Jr. urged media companies to be risk-takers in charging for content and finding sustainable business models online. Wikipedia founder Jimmy Wales, meanwhile, said he sees much more of a future in paid mobile apps than in online news paywalls.
— Finally, two longer pieces to spend some time with this weekend: The Lab published a version of Kimberley Isbell's fabulously helpful primer on aggregation and copyright law, and TechCrunch's Paul Carr wrote an ode to Adam Penenberg's hybrid breaking-news/long-form journalism on Twitter. Great stuff, both.
Similar posts: Purchase Bactrim. Glucophage Cost. Flagyl Cost. Doses Zoloft work. Ordering Bactrim online. Cephalexin recreational.
Trackbacks from: Tramadol For Sale. Tramadol For Sale. Tramadol For Sale. Tramadol from mexico. Buy Tramadol online cod. Tramadol price.
As Jay Rosen surmised after my last Media Musings, this review is largely curated from Twitter, with some RSS thrown […]